slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 92,431-92,460
Pages 3,683
Rows per page 30
Component
92,431-92,460 of 110,471
03
Deliveroo | Results Presentation Deck | 5 slidesDeliveroo | Results Presentation Deck | 5 slides · Deliveroo
Conference presentation Investor relations Beat · What Is1 hit
06
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
19
The slide uses a circular flow diagram to represent the growth algorithm.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
29
The slide uses a house-like structure to represent the capital allocation framework.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
31
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
32
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
66
This slide outlines a classic Traveling Salesperson Problem (TSP) or Vehicle Routing Problem (VRP) approach.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
70
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
83
Includes a DALL-E generated image of a glowing lightbulb.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
84
The diagram uses a funnel metaphor to represent the synthesis of complex problems into specific project outcomes.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
88
The slide uses a network optimization problem as a use case for D-Wave's quantum computing capabilities.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
108
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
114
The slide uses a timeline diagram to show progress milestones.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
115
The scatter plot shows Advantage2 performance on the Y-axis vs Advantage on the X-axis, with a diagonal line indicating parity.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
116
The chart shows residual energy vs rescaled anneal time, highlighting that the mitigated curve achieves lower energy states.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
117
The chart shows residual energy per spin decreasing faster for QA compared to SA and SQA, indicating superior optimization performance.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
118
The slide uses log-log plots to show the scaling gap between classical supercomputing (Frontier/Summit) and quantum annealing.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
02
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
10
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
05
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
07
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
08
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
09
Scientific diagram illustrating the mechanism of antigen presentation and T cell maturation.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
26
The slide contrasts the traditional CRO outsourcing model with a direct management model to justify cost efficiency.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
06
The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for therapeutic intervention.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
19
The chart is a mirrored bar chart (diverging bar chart) showing AE frequency by grade.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
25
Shows efficacy data for ERAS-007 in combination with Encorafenib and Cetuximab.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
26
Includes waterfall plot and swimmer plot for clinical trial results.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
27
Data cutoff 23MAR2023. TRAE = Treatment-related Adverse Event. EC = Encorafenib + Cetuximab.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
32
The chart is a Kaplan-Meier survival plot comparing three treatment groups.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit